Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
OncoImmunity

OncoImmunity

NEC OncoImmunity AS is a bioinformatics company offering proprietary machine learning-based software called the NEC Immune Profiler, which addresses the key knowledge gaps in the prediction of bona fide immunogenic neoantigens for personalized cancer immunotherapy. The NEC Immune Profiler can be used to identify optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable timeframe, and also facilitate effective patient selection for cancer immunotherapy.

Last updated on

About OncoImmunity

Founded

2014

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$7M

Category

Industry

Biotechnology

Location

City

Oslo

State

Oslo

Country

Norway
OncoImmunity

OncoImmunity

Find your buyer within OncoImmunity

Tech Stack (18)

search